CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
2025 · Nature Medicine · 142 citations
https://doi.org/10.1038/s41591-025-03495-z
Y
Yara Abdou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
153
Papers
1.4K
Citations
17
h-index
26
i10-index
Yara Abdou is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Breast Cancer Treatment Studies & Advanced Breast Cancer Therapies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 17, co-authored 131 publications.
ORCID: 0000-0002-4827-8613Papers by this author
worksPACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer
2024 · Journal of Clinical Oncology · 98 citations
https://doi.org/10.1200/jco.23.01940
Racial differences in CD8+ T cell infiltration in breast tumors from Black and White women
2020 · Breast Cancer Research · 39 citations
https://doi.org/10.1186/s13058-020-01297-4
The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients
2022 · Cancer Epidemiology Biomarkers & Prevention · 24 citations
https://doi.org/10.1158/1055-9965.epi-21-1312
Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer
2023 · Clinical Breast Cancer · 24 citations
https://doi.org/10.1016/j.clbc.2023.05.003
Characterization of HER2‐low breast cancer in young women with germline <i>BRCA1/2</i> pathogenetic variants: Results of a large international retrospective cohort study
2024 · Cancer · 18 citations
https://doi.org/10.1002/cncr.35323
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat